BioSpace News Archive

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late- stage intra-tumoral cancer immunotherapies, today announced that Sandra Aung , Ph.D. joined the Company as Senior Vice President, Chief Clinical Development Officer. Dr. Aung will be responsible for overseeing K

Alexion Receives FDA Approval for New Advanced Formulation of ULTOMIRIS ® (ravulizumab-cwvz) with Significantly Reduced Infusion Time – New 100 mg/mL formulation will reduce infusion time by approximately 60 percent, lessening the burden on patients – – ULTOMIRIS is approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) – BOSTON--( BUSINESS WIRE )-- Alexion Pharmaceuticals, Inc.

Dyadic International, Inc., a global biotechnology company focused on further applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, is updating the market on the progress made in certain of its coronavirus programs globally.

Avadyne Health, the patient liability resolution expert, is pleased to announce it has taken the Patient Financial Advocate Pledge and been awarded the Seal indicating patient excellence in financial communication by the American Association of Healthcare Administrative Management (AAHAM) and the National Patient Financial Advocate Task Force.

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the second quarter ended September 30, 2020 on Wednesday, October 28th, 2020 after the Board Meeting.

- Data demonstrates highly reliable test results with 99.56% specificity and 95.00% sensitivity for patients tested 15 days after symptom onset - Availability of the new IgM blood test on the ARCHITECT® and Alinity™ platforms is part of Abbott’s effort to offer tests across the disease progression of COVID-19 - Abbott’s IgM test will give a more complete picture of where patients are in their recovery [12-October-202

Exact Sciences Corp. (NASDAQ: EXAS) today announced the introduction of the Oncotype MAP™ Pan-Cancer Tissue test for patients with advanced, metastatic, refractory, or recurrent cancer. The Oncotype

Responding to the urgent need for additional specialists to treat the growing prevalence of people with Parkinson’s disease (PD), the International Parkinson and Movement Disorder Society hosted the fifth annual " Pan American Section (MDS-PAS) Movement Disorders School for Neurology Residents " on October 10, 2020 . Sponsored by the Ed

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the successful completion of its transaction to acquire 100% ownership of Akcea Therapeutics, Inc. (NASDAQ: AKCA). The combination of Ionis and Akcea accelerates the next phase of Ionis’ gr

New PERSIST-AVR study results and SURE-AVR registry data analysis underscore utility of Perceval as a minimally invasive surgical approach for patients with aortic valve stenosis LONDON--( BUSINESS WIRE )-- LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced new data from the Perceval ® Sutureless Implant Versus Standard-Aortic Valve Replacement (PERSIST-AVR) clinical study and the Sorin Universa